A Meaningful Step Forward for Adults Living with NF1
Health Canada has approved Koselugo (selumetinib) for adults living with NF1 who have symptomatic and inoperable plexiform neurofibromas.
Education Award Applications
NF should never stand in the way of opportunity. The next intake for applications closes April 30.